Oncimmune Holdings PLC (ONC)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

14.50p

Buy

15.00p

arrow-up0.10p (+0.68%)

Prices updated at 29 Nov 2024, 17:15 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
Oncimmune Holdings PLC is a cancer detection company engaged in developing and commercializing its proprietary EarlyCDT platform technology. Its product EarlyCDT-Lung is a simple blood test to aid the risk assessment and early detection of lung cancer.
FTSE All-Share
arrow-up0.07%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
14.90p - 14.90p
31.00p - 9.35p
-
16.54m
-
15,000
14,000
-
106,266.95
1.85
74.14m
GB00BYQ94H38
0.11
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.